Şunu aradınız:: premalignant (İngilizce - Maltaca)

no efficacy study against anal premalignant lesions has been conducted with cervarix.
ma twettaq l-ebda studju tal-effikaċja b’ceravarix kontra l-leżjonijiet anali fi stadju ta’ qabel il-kanċer.

vfend should be discontinued if premalignant skin lesions or squamous cell carcinoma are identified.
vfend għandu jitwaqqaf jekk jiġu identifikati leżjonijiet premalinni tal-ġilda jew karċinoma fiċ-ċelluli skwamużi.

voriconazole accord should be discontinued if premalignant skin lesions or squamous cell carcinoma are identified.
voriconazole accordgħandu jitwaqqafjekk jiġu identifikatileżjonijiet premalinnital-ġildajew karċinoma fiċ-ċelluli skwamużi.

premalignant lesions and cancers affecting the cervix, vulva, vagina and anus caused by vaccine hpv types
leżjonijiet qabel isiru malinni u kanċers li jaffettwaw l-għonq tal-utru, il-vulva, il-vaġina u l- anus ikkawżati mit-tipi ta’ hpv tal-vaċċin

thus gardasil 9 is expected to prevent the majority of cervical, vaginal and vulvar cancers and premalignant lesions, as well as genital warts associated with hpv.
għalhekk gardasil 9 huwa mistenni li jipprevjeni l-maġġoranza tal-kanċers ċervikali, tal-vaġina u vulvari u leżjonijiet premalinni, kif ukoll felul ġenitali assoċjati ma' hpv.

dermatologic evaluation should be performed on a systematic and regular basis, whenever vfend is continued despite the occurrence of phototoxicity-related lesions, to allow early detection and management of premalignant lesions.
evalwazzjoni dermatoloġika għandha titwettaq fuq bażi sistematika u regolari, kull meta vfend jitkompla minkejja l- okkorrenza ta’ leżjonijiet relatati mal-fototossiċità, biex tippermetti l-iżvelar bikri u l-immaniġġjar ta’ leżjonijiet premalinni.

the term "premalignant genital lesions" in section 4.1 corresponds to high-grade cervical intraepithelial neoplasia (cin 2/3), high-grade vulvar intraepithelial neoplasia (vin 2/3) and high- grade vaginal intraepithelial neoplasia (vain 2/3).
it-terminu "leżjonijiet ġenitali premalinni" f’sezzjoni 4.1 jikkorrespondi għal neoplasja intraepiteljali ċervikali ta’ grad għoli (cin 2/3), neoplasja intraepiteljali vulvari ta’ grad għoli (vin 2/3) u neoplasja intraepiteljali vaġinali ta’ grad għoli (vain 2/3).